Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 6.93 M6.79 M6.44 M7.11 M9.06 M7.3 M 29.9 M Research & development —————— — Operating income 26.42 M24.86 M34.75 M40.74 M38.26 M34.9 M 148.66 M Non-Operating Income, Total 707 K3.21 M685 K11.41 M3.81 M9.48 M 25.38 M Interest expense, net of interest capitalized 11.73 M10.9 M11.45 M12.29 M12.01 M12.27 M 48.02 M Non-Operating Income, excl. Interest Expenses -11.12 M-7.75 M-10.81 M-1.13 M-8.59 M-2.75 M -23.27 M Unusual income/expense 94 K53 K47 K245 K380 K-45 K 627 K Pretax income 28.1 M30.93 M33.23 M36.65 M30.91 M32.38 M 133.16 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 14.79 M14.01 M23.35 M27.04 M26.63 M22.59 M 99.61 M Discontinued operations —————— — Net income 14.79 M14.01 M23.35 M27.04 M26.63 M22.59 M 99.61 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 13.99 M13.22 M22.55 M26.28 M25.73 M21.69 M 96.25 M Basic earnings per share (Basic EPS) 0.250.240.40.460.430.36 1.65 Diluted earnings per share (Diluted EPS) 0.250.240.40.460.430.36 1.65 Average basic shares outstanding 55.06 M55.53 M56.69 M56.32 M59.87 M60.58 M — Diluted shares outstanding 55.19 M55.61 M56.76 M56.46 M59.92 M60.74 M — EBITDA 27.91 M30.44 M31.55 M40.68 M31.02 M35.52 M 138.76 M EBIT 26.44 M30.04 M31.16 M40.28 M30.63 M35.08 M 137.14 M Cost of revenue 1.98 M2.44 M2.41 M1.91 M2.01 M2.02 M 8.35 M Other cost of goods sold 1.98 M2.44 M2.41 M1.91 M2.01 M2.02 M 8.35 M Depreciation & amortization (cash flow) 1.47 M394 K394 K395 K390 K443 K 1.62 M